Compounds > pyridoxamine

pyridoxamine and ruboxistaurin

pyridoxamine has been researched along with ruboxistaurin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Tuttle, KR; Williams, ME	1
Williams, ME	1
Shah, SV; Swaminathan, S	1
Bakris, GL; Burney, BO; Kalaitzidis, RG	1
Alicic, RZ; Tuttle, KR	1
Cazenave, M; Gauthier, M; Gueutin, V; Izzedine, H	1

Reviews

6 review(s) available for pyridoxamine and ruboxistaurin

Article	Year
The next generation of diabetic nephropathy therapies: an update. Advances in chronic kidney disease, 2005, Volume: 12, Issue:2 Topics: Animals; Diabetic Nephropathies; Disease Progression; Enzyme Inhibitors; Glycation End Products, Advanced; Glycosaminoglycans; Humans; Indoles; Maleimides; Models, Animal; Protein Kinase C; Pyridoxamine; Renal Agents; Thiazoles	2005
New potential agents in treating diabetic kidney disease: the fourth act. Drugs, 2006, Volume: 66, Issue:18 Topics: Animals; Diabetic Nephropathies; Drugs, Investigational; Glycation End Products, Advanced; Glycosaminoglycans; Humans; Indoles; Maleimides; Protein Kinase C; Protein Kinase Inhibitors; Pyridoxamine; Renal Agents; Treatment Outcome	2006
Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease. Current opinion in nephrology and hypertension, 2008, Volume: 17, Issue:2 Topics: Biomarkers; Chronic Disease; Diabetic Nephropathies; Disease Progression; Drugs, Investigational; Glycation End Products, Advanced; Humans; Indoles; Iron; Kidney; Kidney Diseases; Maleimides; Oxidative Stress; Protein Kinase C; Protein Kinase Inhibitors; Pyridoxamine; Reactive Oxygen Species; Treatment Outcome; Vitamin B Complex	2008
Novel therapies of diabetic nephropathy. Current opinion in nephrology and hypertension, 2009, Volume: 18, Issue:2 Topics: Amides; Animals; Diabetic Nephropathies; Fumarates; Humans; Indoles; Maleimides; Pyridoxamine; Superoxides	2009
Novel therapies for diabetic kidney disease. Advances in chronic kidney disease, 2014, Volume: 21, Issue:2 Topics: Acetylcysteine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Antioxidants; Bosentan; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelins; Enzyme Inhibitors; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Indoles; Janus Kinases; Maleimides; Polyamines; Protein Kinase C; Pyridones; Pyridoxamine; Sevelamer; Sulfonamides	2014
[Diabetic nephropathy: emerging treatments]. Nephrologie & therapeutique, 2014, Volume: 10, Issue:4 Topics: Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Antioxidants; Bone Density Conservation Agents; Diabetic Nephropathies; Doxycycline; Enzyme Inhibitors; Ergocalciferols; Hormones; Humans; Indoles; Maleimides; Octreotide; Pentoxifylline; Pyridones; Pyridoxamine; Silymarin; Vitamin B Complex	2014